Advances in cell therapy: progress and challenges in hematological and solid tumors.

Area of Science:

• Oncology
• Immunology
• Biotechnology

Background:

• Cell-based therapies leverage the immune system to combat cancer, with success in blood cancers.
• Challenges include disease relapse and the tumor microenvironment (TME), limiting broader application.
• Recent progress in cell engineering and TME modulation offers potential solutions.

Purpose of the Study:

• To review challenges and future directions for prominent cell-based cancer therapies.
• To analyze emerging cell types and combination strategies in clinical trials.
• To provide insights into next-generation cell-based cancer treatments.

Main Methods:

• Review of current literature on cell-based therapies.
• Analysis of advancements in gene editing and cell engineering.
• Examination of clinical trial data for cell types like CAR-T, TILs, and NK cells.

Main Results:

• Cell-based therapies face hurdles such as relapse and hostile TME.
• Cell engineering and TME modulation are key to expanding therapy applications.
• Emerging cell types and combination strategies are advancing treatment possibilities.

Conclusions:

• Significant challenges remain for cell-based cancer therapies beyond hematological malignancies.
• Continued innovation in cell engineering and TME targeting is crucial.
• Next-generation therapies hold promise for a wider range of cancers.